Here are 12 key market players:
1. Arthrex
2. Arteriocyte Medical Systems
3. DePuy Synthes
4. Biomet
5. Cesca Therapeutics
6. Dr. PRP America
7. EmCyte Corp.
8. AdiStem
9. Exactech
10. Nuo Therapeutics
11. Regen Lab
12. Harvest Technologies Corp.
More articles on biologics:
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Asterias Biotherapeutics’ stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Ortho RTi receives extension on 2.1M+ warrants: 3 observations
Next Up in Biologics
-
A new review published in The Journal of Bone & Joint Surgery lays out how osteoarthritis develops at the molecular…
-
Researchers at Washington University School of Medicine in St. Louis received $17 million from the Advanced Research Projects Agency for…
-
Platelet-rich plasma and stem cell-based therapies have shown potential to relieve pain and improve function in patients with degenerative disc…
Stay current with Spine Review.
Becker's Spine Review Newsletter is sent Monday–Friday.